Exhibit 99.1
STABLEX TECHNOLOGIES, INC. AND SUBSIDIARIES
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET
JUNE 30, 2025
| Historical | Pro Forma Adjustments | Pro Forma | ||||||||||
| ASSETS | ||||||||||||
| Current assets: | ||||||||||||
| Cash and cash equivalents | $ | 5,132,867 | $ | 6,200,000 | $ | 11,332,867 | ||||||
| Restricted cash | 109,576 | - | 109,576 | |||||||||
| Marketable securities | 3,291,450 | - | 3,291,450 | |||||||||
| Prepaid expenses and other current assets | 296,823 | - | 296,823 | |||||||||
| Total current assets | 8,830,716 | 6,200,000 | 15,030,716 | |||||||||
| Operating lease – right-of-use asset | 331,341 | - | 331,341 | |||||||||
| Deposits and other assets | 32,759 | - | 32,759 | |||||||||
| Total assets | 9,194,816 | 6,200,000 | 15,394,816 | |||||||||
| LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY | ||||||||||||
| Current liabilities: | ||||||||||||
| Accounts payable | $ | 1,034,721 | $ | - | $ | 1,034,721 | ||||||
| Accrued expenses and other current liabilities | 431,308 | - | 431,308 | |||||||||
| Accrued preferred stock redemption payable (H-7) | 5,900,153 | - | 5,900,153 | |||||||||
| Current portion lease obligation – operating lease | 234,376 | - | 234,376 | |||||||||
| Total current liabilities | 7,600,558 | - | 7,600,558 | |||||||||
| Derivative liability | - | 140,000 | (a) | 140,000 | ||||||||
| Warrant liability | 14,537,000 | (14,537,000 | )(b) | - | ||||||||
| Lease obligation - operating lease, net of current portion | 162,336 | 162,336 | ||||||||||
| Total liabilities | 22,299,894 | (14,397,000 | ) | 7,902,894 | ||||||||
| Mezzanine equity: | ||||||||||||
| Redeemable Series H-7 Convertible Preferred Stock ($0.0001 par value per share and $1,000 face value per share; authorized - 22,000 shares; issued and outstanding – 0 shares, at June 30, 2025) Liquidation preference of $0 as of June 30, 2025. | - | - | - | |||||||||
| Redeemable Series I Convertible Preferred Stock ($0.0001 par value per share and $1,000 face value per share; authorized - 7,000 shares; issued and outstanding – 7,000 shares, at June 30, 2025) Liquidation preference of $7,000,000 as of June 30, 2025. | - | 2,909,045 | (a) | 2,909,045 | ||||||||
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, ($0.0001 par value per share; authorized – 20,000,000 shares) | - | - | - | |||||||||
| Series H Convertible Preferred Stock ($0.0001 par value per share; authorized – 8,500 shares; issued and outstanding – 8 shares as of June 30, 2025) Liquidation preference of $0 as of June 30, 2025. | - | - | - | |||||||||
| Convertible Preferred Stock Series H-3 ($0.0001 par value; authorized – 8,461 shares; issued and outstanding – 1,234 shares as of June 30, 2025) Liquidation preference of $59 as of June 30, 2025. | - | - | - | |||||||||
| Series H-6 Convertible Preferred Stock ($0.0001 par value per share; authorized – 50,000 shares; issued and outstanding – 50 shares as of June 30, 2025) Liquidation preference of $287 as of June 30, 2025. | - | - | - | |||||||||
| Common Stock ($0.0001 par value; authorized – 1,200,000,000 shares as of June 30, 2025; issued and outstanding – 590,181 shares as of June 30, 2025) | 59 | - | 59 | |||||||||
| Additional paid-in capital | 117,278,388 | 18,299,000 | (a)(b) | 135,577,388 | ||||||||
| Accumulated deficit | (130,383,525 | ) | (611,045 | )(a) | (130,994,570 | ) | ||||||
| Total stockholders’ equity | (13,105,078 | ) | 17,687,955 | 4,582,877 | ||||||||
| Total liabilities, mezzanine equity and stockholders’ equity | $ | 9,194,816 | $ | 6,200,000 | $ | 15,394,816 | ||||||
Adjustments:
(a) Adjustment reflects the sale of (i) an aggregate of 7,000 shares of Series I Convertible Preferred Stock, with a par value of $0.0001 per share and a stated value of $1,000 per share, of StableX Technologies, Inc. (the “Company”) initially convertible into up to 875,000 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”) at an initial conversion price of $8.00 per share and (ii) warrants to acquire up to an aggregate of 875,000 shares of Common Stock (the “Series I Warrants”) at an initial exercise price of $8.00 per share, pursuant to that certain Securities Purchase Agreement (the “Series I Purchase Agreement”), by and among the Company and the investors signatory thereto, dated as of August 4, 2025 (collectively, the “Private Placement”). The closing of the Private Placement occurred on August 8, 2025. The aggregate gross proceeds from the Private Placement were $7,000,000. The Company incurred total transaction costs of $1.319 million made of cash transaction costs totaling $800,000 and the estimated fair value of the warrants issued to the placement agents totaling approximately $519,000. Net cash proceeds from the Private Placement totaled $6,200,000.
(b) Adjustment reflects the reclassification of (i) certain warrants of the Company (the “Series H-7 Warrants” and, collectively with the Series I Warrants, the “Warrants”) issued pursuant to that certain securities purchase agreement, dated as of August 7, 2023, by and among the Company and the investors signatory thereto (the “Series H-7 Purchase Agreement” and, collectively with the Series I Purchase Agreement, the “Purchase Agreements”), and (ii) Series I Warrants, in each case, from liability-classified to equity-classified as a result of the entrance into that certain Omnibus Amendment, dated as of August 26, 2025, by and among the Company and the Required Holders (as defined in each of the Purchase Agreements) which modified the terms of each of the Warrants such that the Warrants, as modified, are considered to be indexed to the Company’s Common Stock pursuant to ASC 815.